Access 2.8M+ Filings Sign Up Free
Double Bond Pharmaceutical International AB Logo

Double Bond Pharmaceutical International AB | DBP B - Profile, Filings, Stock Info & Investor Relations Data

Double Bond Pharmaceutical International AB | DBP B
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Sweden
Founded
N/A
Double Bond Pharmaceutical International AB (DBP B)

Company Profile

About Double Bond Pharmaceutical International AB

Double Bond Pharmaceutical, DBP, is a pharmaceutical company. The main focus is on the treatment of severe forms of cancer, infections and autoimmune diseases. The research is based on the company's proprietary technology. The products are sold under separate trademarks and collaboration on product development is done together with other players in the field. The company is based in Uppsala.

Headquarters

Virdings Alle 32B
754 50, Uppsala
Sweden

Double Bond Pharmaceutical International AB (DBP B)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Get Notified About Double Bond Pharmaceutical International AB's New Filings

Receive email alerts when new documents are published.

You can unsubscribe at any time.

Double Bond Pharmaceutical International AB (DBP B)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

Double Bond Pharmaceutical International AB (DBP B)
Stock & Investor Information

ISINs

SE0007185517
SE0007185525

LEI

254900U1MWE2YSPREX74

Stock Exchange Listings

Spotlight Exchange

Industry Classification

Sector
Health Care
Industry
Biotechnology